New drug prices spiked in 2023 as Biden seeks to keep costs down
Will Kessler Daily Caller News Foundation Pharmaceutical companies set median starting list prices 35% higher in 2023 than the previous year, despite the Biden administration’s ongoing efforts to tamp down on surging costs, Reuters reported Friday. The median list price for a drug being placed on the market, many of which were for rare diseases,…
Читать дальше...